Data from the 2022 CDC’s National Immunization Survey-Teen survey identified COVID-19 pandemic impacts on adolescent vaccination coverage. For the first time since 2013, the proportion of 13–17-year-olds who received their first dose of the human papillomavirus (HPV) vaccine did not increase. HPV vaccination starting at age 9 can counteract pandemic effects leading to an increase in vaccine completion rates and preventing HPV-related cancers.

In this informative webinar:
• Explore new evidence on the impact of HPV vaccination at age 9.
• Learn from case studies of age 9 success within health departments and healthcare organizations.
• Discuss best practices for the implementation of age 9 activities.

Register: https://us06web.zoom.us/webinar/register/WN_lswbLw3pRMif84qpioM_Vw#/registration